News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
761,538 Results
Type
Article (46933)
Company Profile (326)
Press Release (714261)
Multimedia
Podcasts (124)
Webinars (28)
Section
Business (216083)
Career Advice (2199)
Deals (37073)
Drug Delivery (129)
Drug Development (84081)
Employer Resources (178)
FDA (16975)
Job Trends (15750)
News (363069)
Policy (34082)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2803)
Academic (1)
Accelerated approval (39)
Adcomms (31)
Allergies (160)
Alliances (53736)
ALS (185)
Alzheimer's disease (1763)
Antibody-drug conjugate (ADC) (359)
Approvals (17243)
Artificial intelligence (605)
Autoimmune disease (186)
Automation (48)
Bankruptcy (371)
Best Places to Work (12114)
BIOSECURE Act (21)
Biosimilars (203)
Biotechnology (209)
Bladder cancer (169)
Brain cancer (63)
Breast cancer (672)
Cancer (5174)
Cardiovascular disease (438)
Career advice (1861)
Career pathing (40)
CAR-T (301)
CDC (55)
Celiac Disease (2)
Cell therapy (815)
Cervical cancer (38)
Clinical research (71774)
Collaboration (1937)
Company closure (4)
Compensation (1210)
Complete response letters (66)
COVID-19 (2831)
CRISPR (106)
C-suite (951)
Cystic fibrosis (152)
Data (6600)
Decentralized trials (2)
Denatured (54)
Depression (151)
Diabetes (527)
Diagnostics (7044)
Digital health (51)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (293)
Drug pricing (204)
Drug shortages (28)
Duchenne muscular dystrophy (243)
Earnings (93451)
Editorial (61)
Employer branding (21)
Employer resources (157)
Events (124714)
Executive appointments (1054)
FDA (20260)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1596)
Gene editing (219)
Generative AI (53)
Gene therapy (662)
GLP-1 (1047)
Government (4908)
Grass and pollen (7)
Guidances (387)
Healthcare (19886)
HIV (72)
Huntington's disease (49)
IgA nephropathy (86)
Immunology and inflammation (284)
Immuno-oncology (72)
Indications (134)
Infectious disease (3130)
Inflammatory bowel disease (209)
Inflation Reduction Act (16)
Influenza (127)
Intellectual property (265)
Interviews (344)
IPO (17193)
IRA (53)
Job creations (3982)
Job search strategy (1557)
JPM (65)
Kidney cancer (18)
Labor market (89)
Layoffs (595)
Leadership (37)
Legal (8298)
Liver cancer (99)
Longevity (17)
Lung cancer (695)
Lymphoma (390)
Machine learning (49)
Management (62)
Manufacturing (872)
MASH (176)
Medical device (14454)
Medtech (14520)
Mergers & acquisitions (20980)
Metabolic disorders (1364)
mRNA (183)
Multiple sclerosis (173)
NASH (19)
Neurodegenerative disease (364)
Neuropsychiatric disorders (100)
Neuroscience (3116)
Neurotech (1)
NextGen: Class of 2026 (7003)
Non-profit (4853)
Now hiring (69)
Obesity (649)
Opinion (301)
Ovarian cancer (172)
Pain (218)
Pancreatic cancer (249)
Parkinson's disease (309)
Partnered (38)
Patents (528)
Patient recruitment (544)
Peanut (64)
People (62185)
Pharmaceutical (76)
Pharmacy benefit managers (30)
Phase 1 (22419)
Phase 2 (31551)
Phase 3 (23510)
Pipeline (6036)
Policy (312)
Postmarket research (2670)
Preclinical (9595)
Press Release (70)
Prostate cancer (265)
Psychedelics (53)
Radiopharmaceuticals (304)
Rare diseases (946)
Real estate (6542)
Recruiting (72)
Regulatory (25599)
Reports (53)
Research institute (2596)
Resumes & cover letters (373)
Rett syndrome (30)
RNA editing (19)
RSV (84)
Schizophrenia (159)
Series A (273)
Series B (203)
Service/supplier (13)
Sickle cell disease (105)
Special edition (25)
Spinal muscular atrophy (162)
Sponsored (46)
Startups (3915)
State (2)
Stomach cancer (20)
Supply chain (110)
Tariffs (91)
The Weekly (68)
Vaccines (1085)
Venture capital (97)
Weight loss (423)
Women's health (102)
Worklife (20)
Date
Today (166)
Last 7 days (890)
Last 30 days (3092)
Last 365 days (31270)
2026 (5421)
2025 (31414)
2024 (36472)
2023 (41508)
2022 (52746)
2021 (57441)
2020 (56123)
2019 (49180)
2018 (37122)
2017 (34006)
2016 (33597)
2015 (39716)
2014 (33230)
2013 (28247)
2012 (30398)
2011 (31065)
2010 (29047)
Location
Africa (829)
Alabama (93)
Alaska (7)
Arizona (322)
Arkansas (14)
Asia (42816)
Australia (7061)
California (11942)
Canada (3404)
China (1187)
Colorado (498)
Connecticut (512)
Delaware (348)
Europe (95524)
Florida (1782)
Georgia (388)
Hawaii (3)
Idaho (66)
Illinois (928)
India (77)
Indiana (551)
Iowa (23)
Japan (464)
Kansas (130)
Kentucky (44)
Louisiana (31)
Maine (84)
Maryland (1468)
Massachusetts (8616)
Michigan (347)
Minnesota (665)
Mississippi (7)
Missouri (142)
Montana (36)
Nebraska (29)
Nevada (132)
New Hampshire (86)
New Jersey (3159)
New Mexico (31)
New York (3144)
North Carolina (1602)
North Dakota (10)
Northern California (5841)
Ohio (360)
Oklahoma (22)
Oregon (42)
Pennsylvania (2391)
Puerto Rico (24)
Rhode Island (49)
South America (1202)
South Carolina (70)
South Dakota (1)
Southern California (4665)
Tennessee (191)
Texas (1858)
United States (42533)
Utah (363)
Vermont (1)
Virginia (290)
Washington D.C. (83)
Washington State (970)
West Virginia (4)
Wisconsin (128)
Wyoming (2)
761,538 Results for "discovery partners international inc headquarter".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Artificial intelligence
AI Is Changing Pharma’s Bottom Line Now—But Not Through Splashy Drug Discovery
Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb and AstraZeneca are all ramping up the use of AI, but drug discovery is not the primary success story—yet.
February 11, 2026
·
8 min read
·
Annalee Armstrong
Press Releases
VivaMed BioPharma Partners With Syngene International to Advance AI-Derived Repurposed Therapeutic Programs Through Global Validation Infrastructure
February 19, 2026
·
4 min read
Press Releases
Meiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug Discovery
December 19, 2025
·
2 min read
Press Releases
DW Healthcare Partners Announces Sale of LKC Technologies to AMETEK, Inc.
February 3, 2026
·
2 min read
Press Releases
Genvor, Inc. to Present at the 3rd Annual DealFlow Discovery Conference
January 20, 2026
·
1 min read
Press Releases
BigHat Biosciences Partners With Lilly to Advance Machine-Learning-Enabled Biologics Discovery Through Lilly TuneLab
January 8, 2026
·
2 min read
Press Releases
ABS Bio, Inc. acquires Cureline, Inc. to strengthen support of biopharma drug discovery
January 7, 2026
·
1 min read
Press Releases
Oncotelic Therapeutics, Inc. and Sapu Bioscience Expand International IP Coverage for OT-101, Strengthening CNS and Neurology Commercialization Pathway
February 12, 2026
·
6 min read
Press Releases
Iridex Announces Plans to Relocate Headquarters
February 2, 2026
·
3 min read
Press Releases
OmniAb Enters into a Technology License and Services Agreement for Antibody Discovery with a Newly-Formed Incubated Company of ArrowMark Partners and Viking Global Investors
November 18, 2025
·
5 min read
1 of 76,154
Next
